Transradial left main PCI is safe and effective

EuroIntervention 2018;14:1073-1075. DOI: 10.4244/EIJV14I10A192

Sanjit Jolly
Sanjit S. Jolly1*, MD, MSc; Marco Valgimigli2, MD, PhD
1. Department of Medicine, McMaster University and Population Health Research Institute, Hamilton Health Sciences, Hamilton, Canada; 2. Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland

Multiple large randomised trials including more than 18,000 patients comparing transradial vs. transfemoral access for coronary intervention have shown that transradial access improves outcomes including major vascular complications, bleeding and mortality1-3. The largest trial, the MATRIX trial (Minimizing Adverse Haemorrhagic Events by TRansradial Access Site and Systemic Implementation of angioX, N=8,404) showed a reduction in all-cause mortality with transradial compared to transfemoral access1. However, some operators have been reluctant to use transradial access in complex percutaneous coronary intervention (PCI) such as left main due to the need for larger bore access and increased guide support.

In this issue ...

Sign in to read and download the full article

Forgot your password?

No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Read next article
The evolution of PCI registries: implementing a sustainable future for health systems and clinicians

Latest news